Ameritas Investment Partners, Inc. - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 56 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$53,743
+67.6%
3,094
+35.8%
0.00%
+100.0%
Q2 2023$32,074
+30.9%
2,2780.0%0.00%0.0%
Q1 2023$24,511
-23.1%
2,2780.0%0.00%0.0%
Q4 2022$31,892
+10.0%
2,2780.0%0.00%0.0%
Q3 2022$29,000
+31.8%
2,2780.0%0.00%0.0%
Q2 2022$22,000
-4.3%
2,2780.0%0.00%0.0%
Q1 2022$23,000
-14.8%
2,2780.0%0.00%0.0%
Q4 2021$27,000
+3.8%
2,2780.0%0.00%0.0%
Q3 2021$26,000
-18.8%
2,2780.0%0.00%0.0%
Q2 2021$32,000
-23.8%
2,2780.0%0.00%
-50.0%
Q1 2021$42,000
+5.0%
2,2780.0%0.00%0.0%
Q4 2020$40,000
+14.3%
2,2780.0%0.00%0.0%
Q3 2020$35,000
-18.6%
2,278
+35.6%
0.00%0.0%
Q2 2020$43,000
+186.7%
1,680
+72.3%
0.00%
+100.0%
Q1 2020$15,000
+36.4%
9750.0%0.00%
Q4 2019$11,000
+37.5%
9750.0%0.00%
Q3 2019$8,000
-38.5%
9750.0%0.00%
-100.0%
Q2 2019$13,000
+30.0%
975
+82.2%
0.00%
Q1 2019$10,000
-33.3%
5350.0%0.00%
-100.0%
Q4 2018$15,000
+7.1%
5350.0%0.00%0.0%
Q3 2018$14,0005350.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q3 2018
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,025,000$12,064,0002.56%
GREAT POINT PARTNERS LLC 536,738$6,317,0001.40%
Endurant Capital Management LP 244,125$2,873,0000.69%
HHLR ADVISORS, LTD. 2,920,023$34,369,0000.53%
Integral Health Asset Management, LLC 140,000$1,648,0000.46%
Spearhead Capital Advisors, LLC 235,024$2,766,0000.33%
Jackson Creek Investment Advisors LLC 77,069$907,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 712,807$8,390,0000.30%
Parkman Healthcare Partners LLC 113,644$1,338,0000.30%
Birchview Capital, LP 30,000$353,0000.23%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders